Report Details

Tables and Figures
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antibody Drug Conjugate Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Antibody Drug Conjugate Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Antibody Drug Conjugate Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Antibody Drug Conjugate Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Antibody Drug Conjugate Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugate as of 2021)
Table 10. Global Market Antibody Drug Conjugate Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Antibody Drug Conjugate Sales Sites and Area Served
Table 12. Manufacturers Antibody Drug Conjugate Product Type
Table 13. Global Antibody Drug Conjugate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Antibody Drug Conjugate
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antibody Drug Conjugate Market Challenges
Table 22. Market Restraints
Table 23. Global Antibody Drug Conjugate Sales by Type (K Units)
Table 24. Global Antibody Drug Conjugate Market Size by Type (M USD)
Table 25. Global Antibody Drug Conjugate Sales (K Units) by Type (2017-2022)
Table 26. Global Antibody Drug Conjugate Sales Market Share by Type (2017-2022)
Table 27. Global Antibody Drug Conjugate Market Size (M USD) by Type (2017-2022)
Table 28. Global Antibody Drug Conjugate Market Size Share by Type (2017-2022)
Table 29. Global Antibody Drug Conjugate Price (USD/Unit) by Type (2017-2022)
Table 30. Global Antibody Drug Conjugate Sales (K Units) by Application
Table 31. Global Antibody Drug Conjugate Market Size by Application
Table 32. Global Antibody Drug Conjugate Sales by Application (2017-2022) & (K Units)
Table 33. Global Antibody Drug Conjugate Sales Market Share by Application (2017-2022)
Table 34. Global Antibody Drug Conjugate Sales by Application (2017-2022) & (M USD)
Table 35. Global Antibody Drug Conjugate Market Share by Application (2017-2022)
Table 36. Global Antibody Drug Conjugate Sales Growth Rate by Application (2017-2022)
Table 37. Global Antibody Drug Conjugate Sales by Region (2017-2022) & (K Units)
Table 38. Global Antibody Drug Conjugate Sales Market Share by Region (2017-2022)
Table 39. North America Antibody Drug Conjugate Sales by Country (2017-2022) & (K Units)
Table 40. Europe Antibody Drug Conjugate Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Antibody Drug Conjugate Sales by Region (2017-2022) & (K Units)
Table 42. South America Antibody Drug Conjugate Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Antibody Drug Conjugate Sales by Region (2017-2022) & (K Units)
Table 44. Seattle Genetics/Takeda Antibody Drug Conjugate Basic Information
Table 45. Seattle Genetics/Takeda Antibody Drug Conjugate Product Overview
Table 46. Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. Seattle Genetics/Takeda Business Overview
Table 48. Seattle Genetics/Takeda Antibody Drug Conjugate SWOT Analysis
Table 49. Seattle Genetics/Takeda Recent Developments
Table 50. Roche Antibody Drug Conjugate Basic Information
Table 51. Roche Antibody Drug Conjugate Product Overview
Table 52. Roche Antibody Drug Conjugate Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. Roche Business Overview
Table 54. Roche Antibody Drug Conjugate SWOT Analysis
Table 55. Roche Recent Developments
Table 56. ImmunoGen Antibody Drug Conjugate Basic Information
Table 57. ImmunoGen Antibody Drug Conjugate Product Overview
Table 58. ImmunoGen Antibody Drug Conjugate Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. ImmunoGen Business Overview
Table 60. ImmunoGen Antibody Drug Conjugate SWOT Analysis
Table 61. ImmunoGen Recent Developments
Table 62. Immunomedics Antibody Drug Conjugate Basic Information
Table 63. Immunomedics Antibody Drug Conjugate Product Overview
Table 64. Immunomedics Antibody Drug Conjugate Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Immunomedics Business Overview
Table 66. Immunomedics Antibody Drug Conjugate SWOT Analysis
Table 67. Immunomedics Recent Developments
Table 68. Pfizer Antibody Drug Conjugate Basic Information
Table 69. Pfizer Antibody Drug Conjugate Product Overview
Table 70. Pfizer Antibody Drug Conjugate Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Pfizer Business Overview
Table 72. Pfizer Antibody Drug Conjugate SWOT Analysis
Table 73. Pfizer Recent Developments
Table 74. Celldex Therapeutics Antibody Drug Conjugate Basic Information
Table 75. Celldex Therapeutics Antibody Drug Conjugate Product Overview
Table 76. Celldex Therapeutics Antibody Drug Conjugate Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Celldex Therapeutics Business Overview
Table 78. Celldex Therapeutics Recent Developments
Table 79. Millennium Pharmaceuticals Antibody Drug Conjugate Basic Information
Table 80. Millennium Pharmaceuticals Antibody Drug Conjugate Product Overview
Table 81. Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Millennium Pharmaceuticals Business Overview
Table 83. Millennium Pharmaceuticals Recent Developments
Table 84. Bayer HealthCare Antibody Drug Conjugate Basic Information
Table 85. Bayer HealthCare Antibody Drug Conjugate Product Overview
Table 86. Bayer HealthCare Antibody Drug Conjugate Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Bayer HealthCare Business Overview
Table 88. Bayer HealthCare Recent Developments
Table 89. Mersana Therapeutics Antibody Drug Conjugate Basic Information
Table 90. Mersana Therapeutics Antibody Drug Conjugate Product Overview
Table 91. Mersana Therapeutics Antibody Drug Conjugate Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Mersana Therapeutics Business Overview
Table 93. Mersana Therapeutics Recent Developments
Table 94. Heidelberg Pharma Antibody Drug Conjugate Basic Information
Table 95. Heidelberg Pharma Antibody Drug Conjugate Product Overview
Table 96. Heidelberg Pharma Antibody Drug Conjugate Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Heidelberg Pharma Business Overview
Table 98. Heidelberg Pharma Recent Developments
Table 99. Oxford BioTherapeutics Antibody Drug Conjugate Basic Information
Table 100. Oxford BioTherapeutics Antibody Drug Conjugate Product Overview
Table 101. Oxford BioTherapeutics Antibody Drug Conjugate Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Oxford BioTherapeutics Business Overview
Table 103. Oxford BioTherapeutics Recent Developments
Table 104. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Basic Information
Table 105. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product Overview
Table 106. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Takeda Pharmaceutical Company Limited Business Overview
Table 108. Takeda Pharmaceutical Company Limited Recent Developments
Table 109. Global Antibody Drug Conjugate Sales Forecast by Region (K Units)
Table 110. Global Antibody Drug Conjugate Market Size Forecast by Region (M USD)
Table 111. North America Antibody Drug Conjugate Sales Forecast by Country (2022-2028) & (K Units)
Table 112. North America Antibody Drug Conjugate Market Size Forecast by Country (2022-2028) & (M USD)
Table 113. Europe Antibody Drug Conjugate Sales Forecast by Country (2022-2028) & (K Units)
Table 114. Europe Antibody Drug Conjugate Market Size Forecast by Country (2022-2028) & (M USD)
Table 115. Asia Pacific Antibody Drug Conjugate Sales Forecast by Region (2022-2028) & (K Units)
Table 116. Asia Pacific Antibody Drug Conjugate Market Size Forecast by Region (2022-2028) & (M USD)
Table 117. South America Antibody Drug Conjugate Sales Forecast by Country (2022-2028) & (K Units)
Table 118. South America Antibody Drug Conjugate Market Size Forecast by Country (2022-2028) & (M USD)
Table 119. Middle East and Africa Antibody Drug Conjugate Consumption Forecast by Country (2022-2028) & (Units)
Table 120. Middle East and Africa Antibody Drug Conjugate Market Size Forecast by Country (2022-2028) & (M USD)
Table 121. Global Antibody Drug Conjugate Sales Forecast by Type (2022-2028) & (K Units)
Table 122. Global Antibody Drug Conjugate Market Size Forecast by Type (2022-2028) & (M USD)
Table 123. Global Antibody Drug Conjugate Price Forecast by Type (2022-2028) & (USD/Unit)
Table 124. Global Antibody Drug Conjugate Sales (K Units) Forecast by Application (2022-2028)
Table 125. Global Antibody Drug Conjugate Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Antibody Drug Conjugate
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antibody Drug Conjugate Market Size (M USD), 2017-2028
Figure 5. Global Antibody Drug Conjugate Market Size (M USD) (2017-2028)
Figure 6. Global Antibody Drug Conjugate Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antibody Drug Conjugate Market Size (M USD) by Country (M USD)
Figure 11. Antibody Drug Conjugate Sales Share by Manufacturers in 2020
Figure 12. Global Antibody Drug Conjugate Revenue Share by Manufacturers in 2020
Figure 13. Antibody Drug Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Antibody Drug Conjugate Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Antibody Drug Conjugate Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Antibody Drug Conjugate Market Share by Type
Figure 18. Sales Market Share of Antibody Drug Conjugate by Type (2017-2022)
Figure 19. Sales Market Share of Antibody Drug Conjugate by Type in 2021
Figure 20. Market Size Share of Antibody Drug Conjugate by Type (2017-2022)
Figure 21. Market Size Market Share of Antibody Drug Conjugate by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Antibody Drug Conjugate Market Share by Application
Figure 24. Global Antibody Drug Conjugate Sales Market Share by Application (2017-2022)
Figure 25. Global Antibody Drug Conjugate Sales Market Share by Application in 2021
Figure 26. Global Antibody Drug Conjugate Market Share by Application (2017-2022)
Figure 27. Global Antibody Drug Conjugate Market Share by Application in 2020
Figure 28. Global Antibody Drug Conjugate Sales Growth Rate by Application (2017-2022)
Figure 29. Global Antibody Drug Conjugate Sales Market Share by Region (2017-2022)
Figure 30. North America Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Antibody Drug Conjugate Sales Market Share by Country in 2020
Figure 32. U.S. Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Antibody Drug Conjugate Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Antibody Drug Conjugate Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Antibody Drug Conjugate Sales Market Share by Country in 2020
Figure 37. Germany Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Antibody Drug Conjugate Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Antibody Drug Conjugate Sales Market Share by Region in 2020
Figure 44. China Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Antibody Drug Conjugate Sales and Growth Rate (K Units)
Figure 50. South America Antibody Drug Conjugate Sales Market Share by Country in 2020
Figure 51. Brazil Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Antibody Drug Conjugate Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Antibody Drug Conjugate Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Antibody Drug Conjugate Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Antibody Drug Conjugate Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Antibody Drug Conjugate Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Antibody Drug Conjugate Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Antibody Drug Conjugate Market Share Forecast by Type (2022-2028)
Figure 65. Global Antibody Drug Conjugate Sales Forecast by Application (2022-2028)
Figure 66. Global Antibody Drug Conjugate Market Share Forecast by Application (2022-2028)